5GOLDBERG N S,ROENIGK P K. Neurofibromato- sis, tuberous sclerosis, and other nuurocutaneous dis- orders[M]. In: ARNDT K A, LEBOIT P E, ROB- INSON J K, et al. Cutaneous medicine and surgery: an integrated program in dermatology. Philadelphia:WB Saunders,1996:1729--1741.
6GUTMANN D H, AYLSWORTH A,CAREY J C, et al. The diagnostic evaluation and multidiseiplinary management of neurofibromatosis 1 and neurofibrom- atosis 2[J]. JAMA,1997,278:51--57.
7BRYANT J, FARMER J, KESSLER L J, et al. Pheo- chromocytoma: the expanding genetic differential di- agnosis[J]. J Natl Cancer Inst, 200a, 95: 1196 -- 1204.
8ONOZAWA M, FUKUHARA T, MINOGUCHI M, et al. Hypokalemic rhabdomyolysis due to WDHA syndrome caused by VIP-producing composite pheo- chromocytoma:a case in neurofibromatosis type l[J]. Jpn J Clin Oncol,2005,35:559-563.
9MAHAJAN H, LEE D, SHARMA R,et al. Compos- ite phaeochromocytoma-ganglioneuroma, an unegm- mon entity., report of two cases[J].Pathology,2010; 42:295--298.
10TANCIС-GAJI С M, VUJOVI С2 S, TATI С S, et al. Adrenal incidentaloma in neurofibromatosis type 1 [J]. Srp Arh Celok Lek,2008,136:295--298.
